RIBOLSI, MENTORE
 Distribuzione geografica
Continente #
AS - Asia 3.360
NA - Nord America 654
EU - Europa 332
AF - Africa 17
SA - Sud America 16
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.392
Nazione #
SG - Singapore 2.811
US - Stati Uniti d'America 599
CN - Cina 319
HK - Hong Kong 180
GB - Regno Unito 95
IT - Italia 84
DE - Germania 56
CA - Canada 31
MX - Messico 24
IN - India 20
NL - Olanda 17
FI - Finlandia 13
FR - Francia 11
AU - Australia 10
BR - Brasile 10
UA - Ucraina 8
ZA - Sudafrica 8
AT - Austria 7
CZ - Repubblica Ceca 7
PL - Polonia 7
ES - Italia 6
JP - Giappone 6
EE - Estonia 5
AR - Argentina 4
BD - Bangladesh 3
EG - Egitto 3
ET - Etiopia 3
PK - Pakistan 3
RO - Romania 3
SE - Svezia 3
TR - Turchia 3
BE - Belgio 2
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
KR - Corea 2
PT - Portogallo 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BO - Bolivia 1
EC - Ecuador 1
IM - Isola di Man 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MA - Marocco 1
ME - Montenegro 1
MY - Malesia 1
NR - Nauru 1
PW - Palau 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TZ - Tanzania 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.392
Città #
Singapore 194
Hong Kong 173
Hefei 171
Ashburn 147
London 79
Boardman 78
Beijing 56
Shanghai 49
Dallas 43
Council Bluffs 33
Rome 31
Santa Clara 30
Munich 29
Los Angeles 27
Mexico City 19
Burlington 18
New York 13
Pune 13
San Francisco 13
Seattle 13
Brooklyn 12
Amsterdam 10
West Jordan 10
Chicago 9
Washington 9
Buffalo 8
Secaucus 8
Turku 8
Toronto 7
Warsaw 7
Guangzhou 6
Helsinki 5
Johannesburg 5
Brno 4
Hangzhou 4
Milan 4
Paris 4
Phoenix 4
Sona 4
Addis Ababa 3
Chengdu 3
Chennai 3
Frankfurt am Main 3
Guiyang 3
Hamburg 3
Melbourne 3
Olomouc 3
San Jose 3
Stockholm 3
São Paulo 3
Vienna 3
Volla 3
Adelaide 2
Atlanta 2
Bangkok 2
Banī Suwayf 2
Bolzano 2
Boydton 2
Brescia 2
Brookline 2
Brussels 2
Canberra 2
Denver 2
Dhaka 2
Falkenstein 2
Fino Mornasco 2
Jackson 2
Liverpool 2
Maia 2
Manchester 2
Markham 2
Messina 2
Nuremberg 2
Oaxaca City 2
Queens 2
Santa Fe 2
Sydney 2
Taipei 2
Tokyo 2
Wandsworth 2
Wuhan 2
10th of Ramadan City 1
Alba Iulia 1
Ananindeua 1
Ankara 1
Annapolis 1
Araçatuba 1
Bengaluru 1
Bertamirans 1
Bishkek 1
Boston 1
Buenos Aires 1
Cañuelas 1
Central 1
Changsha 1
Charlotte 1
Chenzhou 1
Cholula 1
City of London 1
Concord 1
Totale 1.473
Nome #
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure 211
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 197
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 195
Effect of oesophagitis on proximal extent of gastro-oesophageal reflux. 186
Clinical impact of proton pump inhibitor response and dependence 185
Effect of the gatekeeper reflux repair system on intra-esophageal distribution of acid reflux in gastroesophageal reflux disease patients: Relation with typical symptoms 184
Applying Lyon Consensus criteria in the work‐up of patients with proton pump inhibitory‐refractory heartburn 184
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 182
Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients 176
Chicago Classification v4.0 Stratifies Acid Burden and Abnormal Impedance-pH Variables Better Than Chicago Classification v3.0 Chicago Classification v4.0 and GERD 114
Achalasia, from diagnosis to treatment 108
Association between dietary habits and fecal microbiota composition in irritable bowel syndrome patients: A pilot study 108
Association between post-reflux swallow-induced peristaltic wave index and esophageal mucosal integrity in patients with GERD symptoms 105
Application of Lyon Consensus criteria for GORD diagnosis: evaluation of conventional and new impedance-pH parameters 105
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 102
Anxiety correlates with excessive air swallowing and PPI refractoriness in patients with concomitant symptoms of GERD and functional dyspepsia 94
Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn’s disease 94
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux 93
Breathing training on lower esophageal sphincter as a complementary treatment of gastroesophageal reflux disease (GERD): a systematic review 91
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 89
Effect of hiatal hernia on proximal oesophageal acid clearance in gastro-oesophageal reflux disease patients 82
Esophageal pH increments associated with post-reflux swallow-induced peristaltic waves show the occurrence and relevance of esophago-salivary reflex in clinical setting 81
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 77
Dilated intercellular spaces and acid reflux at the distal and proximal oesophagus in patients with non-erosive gastro-oesophageal reflux disease 63
Impaired colonic contractility and intestinal permeability in symptomatic uncomplicated diverticular disease 63
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 52
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 35
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 34
Esophageal and Oropharyngeal Dysphagia: Clinical Recommendations From the United European Gastroenterology and European Society for Neurogastroenterology and Motility 33
Palmitic acid affects intestinal epithelial barrier integrity and permeability in vitro 33
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 32
Baseline impedance levels and structural and functional integrity of the esophageal mucosa: is acid still the only player? 32
Psychological distress in inflammatory bowel disease 32
Intra-oesophageal distribution and perception of acid reflux in patients with non-erosive gastro-oesophageal reflux disease 31
Ambulatory reflux monitoring for diagnosis of gastro-esophageal reflux disease: Update of the Porto consensus and recommendations from an international consensus group 28
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 27
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 26
Prospective validation of reflux monitoring by impedance-pH in predicting PPI response in typical GERD 26
Relevance of Excessive Air Swallowing in GERD Patients With Concomitant Functional Dyspepsia and Poor Response to PPI Therapy 25
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 23
PATIENTS WITH EXTRA-ESOPHAGEAL SYMPTOMS, COMPARED TO NERD PATIENTS WITH TYPICAL SYMPTOMS AND HEALTHY VOLUNTEERS, ARE CHARACTERIZED BY A HIGHER NUMBER OF REFLUX EPISODES AND HIGHER PROPORTION OF WEAKLY ACIDIC AND MIXED REFLUX 23
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 23
Role of Overweight and Obesity in Gastrointestinal Disease 22
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis 21
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls 21
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 21
High-resolution Manometry Determinants of Refractoriness of Reflux Symptoms to Proton Pump Inhibitor Therapy 21
Classification of esophageal motor findings in gastro-esophageal reflux disease: Conclusions from an international consensus group 21
Proximal esophageal impedance baseline increases the yield of impedance-pH monitoring for GERD diagnosis and is associated with heartburn response to PPI 20
Post-reflux swallow-induced peristaltic wave index and mean nocturnal baseline impedance predict PPI response in GERD patients with extra esophageal symptoms 20
Nutritional aspects in inflammatory bowel diseases 20
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 20
Reflux characteristics triggering post-reflux swallow-induced peristaltic wave (PSPW) in patients with GERD symptoms 19
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 19
New classifications of gastroesophageal reflux disease: an improvement for patient management? 19
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 19
Understanding the relationship between esophageal motor disorders and reflux disease 18
Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus 18
Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease 17
Normal values and regional differences in oesophageal impedance-pH metrics: a consensus analysis of impedance-pH studies from around the world 17
Dilated intercellular space diameter as marker of reflux-related mucosal injury in children with chronic cough and gastro-oesophageal reflux disease 17
Relationship between baseline impedance levels and esophageal mucosal integrity in children with erosive and non-erosive reflux disease 16
Maintenance of remission with infliximab in inflammatory bowel disease: Efficacy and safety long-term follow-up 16
Short duration of acid exposure sensitizes the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease (NERD) patients 16
Intercellular space diameters of the oesophageal epithelium in NERD patients: head to head comparision between light and electron microscopy 16
Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease 16
Fragmented and failed swallows on esophageal high-resolution manometry associate with abnormal reflux burden better than weak swallows 16
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring 15
Italian guidelines for the diagnosis and management of gastro-esophageal reflux disease: Joint consensus from the Italian Societies of: Gastroenterology and Endoscopy (SIGE), Neurogastroenterology and Motility (SINGEM), Hospital Gastroenterologists and Endoscopists (AIGO), Digestive Endoscopy (SIED), and General Medicine (SIMG) 15
Measurement of acid exposure of proximal esophagus: a better tool for diagnosing non-erosive reflux disease 15
Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease 14
Patients With Definite and Inconclusive Evidence of Reflux According to Lyon Consensus Display Similar Motility and Esophagogastric Junction Characteristics 14
Postreflux swallow-induced peristaltic wave index from pH-impedance monitoring associates with esophageal body motility and esophageal acid burden 13
An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders 12
Oesophageal mucosal intercellular space diameter and reflux pattern in childhood erosive and non-erosive reflux disease 12
Artificial Intelligence in the Diagnosis of Upper Gastrointestinal Diseases 12
Exploring the association between esophageal mucosal inflammation, impaired motility, and GERD severity 11
Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 11
Letter: is wireless oesophageal pH monitoring the best technique to evaluate night‐time reflux? 10
Proximal esophageal impedance baseline increases the yield of impedance‐pH and is associated with response to PPIs in chronic cough patients 10
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions 9
Towards a better diagnosis of gastro esophageal reflux disease 9
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis 9
The Lyon Consensus: Does It Differ From the Previous Ones? 9
Advancements in the use of 24-hour impedance-pH monitoring for GERD diagnosis 9
Exploring the Complex Interplay Between Ineffective Esophageal Motility and Reflux Burden 8
Esophageal chest pain resembles heartburn in reflux metrics and response to proton pump inhibitor therapy 8
Practice guidelines on the use of esophageal manometry – A GISMAD-SIGE-AIGO medical position statement 8
Editorial: inconclusive diagnosis of GERD: are new parameters in impedance‐pHmetry ready for clinical use? Authors' reply 8
Encouraging appropriate use of proton pump inhibitors: existing initiatives and proposals for the future 7
Nonachalasic esophageal motor disorders, from diagnosis to therapy 7
Letter to the Editor: Relevance of a Correct GERD Patient Classification Before Anti-reflux Procedures 7
Modern Diagnosis of Early Esophageal Cancer: From Blood Biomarkers to Advanced Endoscopy and Artificial Intelligence 6
On‐therapy impedance‐pH monitoring can efficiently characterize PPI‐refractory GERD and support treatment escalation 6
Esophageal motility disorders among elderly patients: An international multicenter study 6
Should we have to include transcutaneous neuromodulation in the therapeutic GERD armamentarium? 6
Topical Protection of Esophageal Mucosa as a New Treatment of GERD 6
Editorial: Lyon consensus metrics—towards personalised diagnosis of non‐erosive reflux disease: Authors' reply 5
Letter: the potential link between oesophageal hypervigilance, visceral anxiety, increased swallow rate and oesophageal mucosal integrity 5
Letter: should we have to include baclofen in the GORD therapy armamentarium? 5
Totale 4.457
Categoria #
all - tutte 28.930
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.930


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202283 0 0 2 0 0 2 0 2 0 3 0 74
2022/202333 1 0 0 2 0 1 0 2 0 0 27 0
2023/2024331 5 35 42 23 18 137 3 27 3 17 15 6
2024/20253.468 39 24 117 26 42 75 62 16 230 208 1.127 1.502
2025/2026542 355 187 0 0 0 0 0 0 0 0 0 0
Totale 4.457